Fidson, pharmaceutical company to boost local drug production

September 4, 2025 by Our Reporter

Fidson Healthcare Plc has deepened its strategic alliance with Japan’s Ohara Pharmaceutical Company at the Ninth Tokyo International Conference on African Development (TICAD9), a platform that fosters stronger partnerships between Japan and Africa.

Fidson’s delegation, led by Managing Director, Mr. Abiola Adebayo, with Finance Director, Imokha Ayebae, and Business Development and Marketing Director, Oshoke Ayebae, unveiled details of the partnership. Ohara will support Fidson’s capital raise while offering strategic guidance from Japan’s pharmaceutical expertise. The collaboration will enhance Fidson’s capacity to produce more specialised drugs for diverse diseases.

Adebayo described the development as a milestone in Fidson’s journey, noting that the partnership reflects confidence in the company and underscores a shared commitment to advancing healthcare in Africa: “Putting this alliance on a world stage emphasises the fact that Fidson-Ohara collaboration has come to stay.” he said.

Read Also: TALI partners government on enforcement of disability rights in Nigeria

The foundation of Fidson-Ohara partnership was laid in July, 2019, following Fidson’s rights issue. The core of this collaboration was transfer of expertise, and innovation from Ohara, a company specialising in medicines for critical therapeutic areas, particularly pediatric oncology and generic medicines. The partnership was a direct response to Nigeria’s over-reliance on imported medicines. Adebayo said:

“By leveraging Ohara’s technical know-how and experience, the partnership has strengthened local production capacity, improved quality and affordability of medicines, and ultimately reduced the country’s dependence on foreign supplies.”

This deeper commitment by Ohara will accelerate transfer of more advanced production processes and research capabilities, enabling Fidson to produce a wider range of high-quality, local medicines, including specialised drugs. This, combined with access to Ohara’s portfolio of innovative drugs, will position Fidson to meet demand for life-saving medicines in Africa. “This intention by Ohara is a welcome idea to scale up Fidson’s operations. It will enable Fidson to expand into areas critical to Africa’s healthcare needs like API production, and other innovations pioneered by Ohara.” Adebayo said.

The announcement at TICAD9 underscores the unwavering commitment of both companies to this strategic partnership. For Ohara, it provides significant expansion across the dynamic African market, while for Fidson, it reinforces its position as the leader in Nigeria’s pharmaceutical industry, and a force to reckon with In Africa. In his statement, the President and CEO of Ohara Pharmaceutical Co., Ltd., Dr. Seiji Ohara said: “Since the beginning of our collaboration, Ohara and Fidson have built a sincere and trusting relationship through numerous meetings and visits. We at Ohara are delighted to have now signed a Memorandum of Understanding based on this trust, allowing us to explore ways to further strengthen our relationship with Fidson. Going forward, we hope to contribute to the realization of two key values— the growth of Fidson’s business and the mission of saving more lives— by maintaining our excellent partnership and connecting them with the latest innovations and technologies.”

Abuja doctor reveals a unique way to permanently cure weak erection, small and shameful manhood, and infertility issues without side effects within a short period. Click now to see!!

Professionals in Nigeria can now earn US Dollars Monthly ($25,000 to $45,000) from Civil and Public Servants, IT Professionals, Doctors, Engineers, Senior Bankers, Entrepreneurs, Military Personnel, Lawyers, Finance experts and others. You can now confidently earn in US Dollars while in Nigeria. Click here to start.